NCT04095858 · Interventional trial
Efprezimod Alfa (CD24Fc, MK-7110) for the Prevention of Acute Graft Versus Host Disease (GVHD) Following Myeloablative Hematopoietic Stem Cell Transplantation (HSCT) (MK-7110-005)
Overall registry status Terminated
Phase 3
Conditions Acute Graft Versus Host Disease, Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Hematopoietic Stem Cell Transplantation, Myelodysplastic Syndromes
Delaware Valley sites
- Abramson Cancer Center of the University of Pennsylvania ( Site 0309) · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory